-
公开(公告)号：US12128083B2
公开(公告)日：2024-10-29
申请号：US18450553
申请日：2023-08-16
发明人： Gerold L. Mosher , David W. Miles
IPC分类号： A61K38/05 , A61K9/00 , A61K31/401 , A61K38/00 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26
CPC分类号： A61K38/05 , A61K9/0053 , A61K9/0095 , A61K31/401 , A61K38/005 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26
摘要： Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
-
公开(公告)号：US20240299485A1
公开(公告)日：2024-09-12
申请号：US18663349
申请日：2024-05-14
发明人： Gerold L. MOSHER , David W. MILES
IPC分类号： A61K38/05 , A61K9/00 , A61K31/401 , A61K38/00 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26
CPC分类号： A61K38/05 , A61K9/0053 , A61K9/0095 , A61K31/401 , A61K38/005 , A61K45/06 , A61K47/02 , A61K47/12 , A61K47/26
摘要： Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
-
公开(公告)号：US20240285527A1
公开(公告)日：2024-08-29
申请号：US18402960
申请日：2024-01-03
发明人： Ken FALLIN , Zeus PENDON , Priya CAPILA , Neal MUNI
IPC分类号： A61K9/10 , A61K9/00 , A61K9/107 , A61K31/197 , A61K31/4164 , A61K47/08 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/46 , A61P21/00 , A61P21/02 , A61P25/28 , A61P31/04 , A61P33/02
CPC分类号： A61K9/10 , A61K9/0053 , A61K9/0095 , A61K9/107 , A61K31/197 , A61K31/4164 , A61K47/08 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/46 , A61P21/02 , A61P31/04 , A61P33/02 , A61P21/00 , A61P25/28 , Y02A50/30
摘要： Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
-
公开(公告)号：US20240082230A1
公开(公告)日：2024-03-14
申请号：US18484564
申请日：2023-10-11
发明人： Hugh Greg THOMAS
IPC分类号： A61K31/4422 , A61K9/08 , A61K47/10 , A61P25/00
CPC分类号： A61K31/4422 , A61K9/08 , A61K47/10 , A61P25/00
摘要： Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.
-
公开(公告)号：US11806338B2
公开(公告)日：2023-11-07
申请号：US17530728
申请日：2021-11-19
发明人： Hugh Greg Thomas
IPC分类号： A61K31/4422 , A61K47/10 , A61K9/08 , A61P25/00
CPC分类号： A61K31/4422 , A61K9/08 , A61K47/10 , A61P25/00
摘要： Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.
-
公开(公告)号：US20230301907A1
公开(公告)日：2023-09-28
申请号：US17954703
申请日：2022-09-28
发明人： Indu Muni , Peter Mione , Anisa Gandhi , Cristina LeChiara
CPC分类号： A61K9/08 , A23L2/52 , A23L2/56 , A23L2/60 , A61K9/0095 , A61K38/14 , A61K47/12 , A61K47/26 , A23V2002/00
摘要： The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
-
7.发明公开公开(公告)号：US20230218586A1
公开(公告)日：2023-07-13
申请号：US18114469
申请日：2023-02-27
IPC分类号： A61K31/423 , A61K47/12 , A61K9/10 , A61K47/36 , A61K9/00 , A61K47/24 , A61K47/26 , A61K9/08 , A61K47/38
CPC分类号： A61K31/423 , A61K47/12 , A61K9/10 , A61K47/36 , A61K9/0095 , A61K47/24 , A61K9/0053 , A61K47/26 , A61K9/08 , A61K47/38
摘要： The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
-
公开(公告)号：US20220370349A1
公开(公告)日：2022-11-24
申请号：US17881785
申请日：2022-08-05
发明人： Ken FALLIN , Zeus PENDON , Priya CAPILA , Neal MUNI
IPC分类号： A61K9/10 , A61K47/12 , A61K47/46 , A61P31/04 , A61K47/36 , A61K31/4164 , A61P33/02 , A61K47/34 , A61K31/197 , A61K47/38 , A61K9/00 , A61K47/26
摘要： Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
-
公开(公告)号：US20220241197A1
公开(公告)日：2022-08-04
申请号：US17725923
申请日：2022-04-21
发明人： Ken FALLIN , Zeus PENDON , Priya CAPILA , Neal MUNI
IPC分类号： A61K9/10 , A61K31/4164 , A61K47/12 , A61K47/26 , A61K47/34 , A61K47/38 , A61K47/46 , A61K31/197 , A61P33/02 , A61P31/04 , A61K9/00 , A61K47/36
摘要： Suspensions of metronidazole or baclofen and/or salts or ester derivative thereof, such as metronidazole benzoate, are disclosed. The suspension my include metronidazole or baclofen, and/or a salt or ester derivative thereof a hydrocolloid stabilizer, simethicone emulsion, a buffer, such as sodium citrate, (dihydrate), a preservative, a thickening agent, a sweetener, and water.
-
公开(公告)号：US11173141B2
公开(公告)日：2021-11-16
申请号：US17338436
申请日：2021-06-03
发明人： Gerold L. Mosher , David W. Miles
IPC分类号： A61K31/401 , A61K9/00 , A61K47/26 , A61K47/12
摘要： Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
-
-
-
-
-
-
-
-
-
搜索结果
65 条记录 (耗时 0.03 秒)
